Bank of Montreal’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bank of Montreal’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-28,500	Closed	-$510K	–	4058
2021 Q3	$510K	Buy	+28,500	New	+$333K	﹤0.01%	2867

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Bank of Montreal's TRIL Position: Q4 2021 in Review

Bank of Montreal sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 37,230 shares — an estimated $666K sold.

Bank of Montreal first reported a position in TRIL in Q3 2015 and held it in 11 quarters. The position peaked at $2.76M in Q1 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Bank of Montreal reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Bank of Montreal sold 37,230 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $666K.
Bank of Montreal first reported a position in Trillium Therapeutics Inc. in Q3 2015 and held it in 11 quarters.
Bank of Montreal's Trillium Therapeutics Inc. position peaked at $2.76M in Q1 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.